The main activities ofthe Forum since its inception have been: (a) to form working parties to produce reports on subjects of mutual concern to the medical profession and the industry; (b) to organize symposia or workshops on relevant subjects; (c) to publish booklets on appropriate topics. A full list of publications is available from the Forum officeor from the ABPI, but in recent years events of note have been meetings on such subjects as: Medicine and the media; Education of medical students in relation to drug development, safety and efficacy; Biomedical research involving human subjects; Informing patients about medicines. There have been working parties on: Clinical trials; Medicine and the media; and Medical student education. Many of these have resulted in publications or reports.
Weare looking forward to an interesting programme during the next two years under the Chair-
letters to the Editor
Preference is given to letters commenting on contributions published recently in the JRSM. The usual length of letters is up to 400 words (one table or illustration may be included) and they should be typed in double spacing.
Admission to medical school: from audit to action Sir, I read with interest the editorial on this subject by Horton (September 1986 JRSM, p 504), though was a little disturbed to read that 'it is naturally desirable that factors such as medical parents, social class, private education, race and sex do not become significant predictors of shortlisting or interview success'. I wonder what evidence Mr Horton has when he suggests that the potential student who has been brought up in a medical family and thereby knows a number of the problems, who comes from social class A or B, whose parents have sacrificed a considerable portion of their income to ensure that he has a good education, and who is British and male, has not all the qualifications for becoming a first-class doctor, be he general practitioner or hospital consultant.
RoGER GRACE Consultant Surgeon The Royal Hospital, Wolverhampton

*Dr Horton replies below:
Sir, I am not aware of any evidence from the literature to refute or support the contention that those who possess the qualities stated by Mr Grace would not become excellent doctors. However, this was not the point being made. I was attempting to discuss the proposal that, at a time of increasing competition for potentially fewer places at medical school, admissions procedures ought to be audited in order to ensure total impartiality in selection. There certainly is evidence that this is not the case.
Collier and Burkel analysed the sex and race of final year students at London medical schools between 1982 and 1984 and found significant differences in the proportions of women and non-whites between the different schools. These differences remained consistent from year to year, suggesting it was not merely due to chance alone. They concluded that significant racial and sexual discrimination was operating within those schools studied.
It is the rather alarming evidence of this sort which provides the impetus for monitoring student admissions to medical school. RICHARD Dihydroneopterin triphosphate and BH 4 give rise to a mixture of tetrahydro-, dihydroand fully oxidized derivatives in body tissues and fluids. These can be conveniently measured by high-performance liquid chromatography, after acid/iodine oxidation to convert all the derivatives into the fully oxidized fluorescent forms neopterin (N) and biopterin (B)4, Reduced BH 4 synthesis can be shown by significantly lowered levels of B. A deficit in the conversion The measurement of neopterin and biopterin derivatives in body fluids of control subjects and those diagnosed as having AD have shown marked differences between the two groups. In urine the N:B ratio is significantly elevated in AD subjects compared with age-matched controls ( Table 1 ). In plasma and cerebrospinal fluid (CSF) the biopterin levels are reduced in AD while neopterins are not significantly different compared to controls (Table 1 ). Brain biopterins from AD subjects, measured at post-mortem, show a decrease whilst the neopterins increase. These results suggest that the decline in the levels of total biopterins is due to a reduced conversion of dihydroneopterin triphosphate to BH 4~.
Post-mortem human brain tissue shows a reduced level ofBH 4 synthesis in AD temporal lobe (BA 20) 12 and the locus ceruleus'P but not the frontal cortex (BA 9)13. Both the locus ceruleus and the temporal lobe are known to be severely affected in AD. Biosynthesis of BH 4 requires three enzymes: GTP cyclohydrolase, phosphate eliminating enzyme and sepiapterin reductase. Measurements of enzyme activity for sepiapterin reductase and GTP cyclehydrolase have found both to be spared in AD, suggesting that the lesion must be at the level of phosphate-eliminating enzyme13. BH 4 synthesis in human temporal and frontal lobes declines with age through a reduced ability to convert dihydroneopterintriphosphate to tetrahydrobiopterin due to reduced phosphate-eliminating enzyme capacity, and we suggest that AD may be an accelerated form of this process 14. Recent observations have shown a correlation between changes in the visual evoked potential in AD and the severity of the diseasa'? and we have observed a positive correlation with the visual evoked potential and the neopterin to biopterin ratio in urine (paper in preparation).
We suggest that the primary lesion in AD is a failure in BH 4 metabolism in the locus ceruleus, which is known to have strong innervative noradrenergic links with the olfactory bulb!", providing a trigger for the spreading degeneration from the olfactory bulb, and which would also explain the noradrenergic deficit (referred to by Harrison) and hyperphenylalaninaemia found in AD 17 I used to find children's ears shortly after a 'dry tap' still showed all the signs and test results of a 'glue ear'. It seems logical to me to expect the fluid in a partially-filled middle ear-mastoid system to gravitate into the mastoid when a child is lying on its back at operation. This would allow any air to rise to the middle ear to give the 'dry tap'. I always teach trainees to decide if a grommet is needed before making the myringotomy. J H NEAME Od.tock Hospital, Salisbury Joan of Are, creative psychopath: is there another explanation?
Sir, Like Dr Moore (September 1986 JRSM, p 560) I remain unconvinced by Dr Ratnasuryia's 'explanation' for the progress of Joan of Arc from simple country girl to successful warrior (April JRSM, p 234). Even if she did suffer from tuberculosis, as Dr Ratnasuryia suggests, such a handicap fails to explain the outstanding qualities of courage and resolution shown by this remarkable woman. In our secular age it has become fashionable to invoke some kind of psychopathological reductionism to account for some of the heroic qualities manifested by individals in bygone times, whose behaviour seems almost Inexplicable when judged by present-day standards; Somehave subsequently been canonized as Saints. Knowing all too well what lay in store for her, only once did she weaken and sign a document of abjuration, which she withdrew soon afterwards. In the end her religious faith saw her through to the stake and one can but hope that this was sufficient to Journal of the Royal Society of Medicine Volume 80 February 1987 129 help her overcome her very understandable fears of an appallingly painful death. Whether or not her visual and auditory hallucinations were products of a cerebral lesion is immaterial. She acted upon them within the principles of her religion in which she implicitly believed. One needs more than a tuberculoma to emulate St Joan's achievements. I have had no personal experience with this type of porphyria, but I have had excellent results in two patients with porphyria cutanea tarda and I have reported additional references in this type of porphyria with the administration of large doses of a potent form of vitamin E over a considerable period of time. In view of the clinical appearance and the tendency of photosensitivity of both types of porphyria, I think it is possible that vitamin E therapy might be of value. In my two patients, vitamin E was prescribed in the form of d, alpha-tocopheryl acetate 400iu four times a day before meals and at bedtime. The skin lesions and the photosensitivity, as well as urinary porphyrins, responded over a period of several months I, Other reports on the control of porphyria cutanea tarda with vitamin E therapy have also been published-".
I have seen no undesirable side effects from vitamin E therapy as described. Inorganic iron and female hormones tend to combine with and inactivate vitamin E and should be avoided. Patients with hypertension and diabetic patients on therapy should be started on 100iu once daily, which can be gradually increased while monitoring the blood pressure or the blood glucose. Sir, The purpose of our paper was to describe the clinical and biochemical features of homozygous variegate porphyria. We note with interest Dr Ayres' comments on the apparent response of porphyria cutanea tarda to vitamin E, and will consider its use together with more conventional measures in the future management of our patients. G M MURPHY St John's Hospital for Diseases of the Skin, London
